Our Drug Substance Capabilities

Image

Microbial Fermentation

Australia's most established commercial-scale microbial fermentation platform, with over 40 years of continuous operation and fermentation scale from process development through to 500 L cGMP commercial supply.
Explore Microbial Fermentation
Image

Plasmid DNA

cGMP plasmid DNA manufacturing from preclinical milligram quantities through to commercial gram-scale batches, serving mRNA template supply, gene therapy vector production, DNA vaccines, and CRISPR delivery programs.
Explore Plasmid DNA
Image

mRNA

End-to-end GMP mRNA drug substance manufacturing from in vitro transcription through to purification and formulation, with an integrated upstream pathway connecting in-house plasmid DNA manufacturing and downstream LNP encapsulation.
Explore mRNA Manufacturing
Image

Lipid Nanoparticle (LNP)

GMP lipid nanoparticle encapsulation for a broad range of payloads using precision microfluidic technology, from early formulation development through to commercial-scale manufacture, with full flexibility for client-proprietary lipid systems.
Explore LNP

Program Lifecycle From Concept to Commercial

A lab technician performing a manual visual inspection in a sterile pharmaceutical cleanroom.
01

Concept and Design

Sequence evaluation, expression system selection, and manufacturing strategy aligned to your regulatory and commercial objectives.
Image
02

Cell Line Development and Process Design

Host strain selection, cell banking, and early process development establishing the biological foundation of your program.
Image
03

Process Development and Optimization

Scale-up from bench to cGMP scale, with process characterization and optimization designed for reproducibility and regulatory confidence.
Image
04

Scale-Up Readiness

Tox batches, process validation, and technology transfer preparing your program for cGMP manufacturing.
Image
05

Commercial Manufacturing and Supply

cGMP manufacturing campaigns, quality release, and ongoing commercial.

Why BioCina for Your Drug Substance Program

Our team has spent decades taking biologics programs from early clinical supply through to globally shipped commercial product. We understand the science, the scale, the regulatory complexity, and logistics that your drug substance programs demand.
Image

Any Sequence at Any Stage

From a target sequence to a fully developed process, our capabilities adapt to meet your program exactly where it is.
Image

From Drug Substance to Drug Product

An integrated pathway from bulk drug substance through to sterile fill-finish, delivering continuity and confidence from first batch to finished medicine.
Image

Deep Biologics Expertise

From early clinical supply to full commercial manufacturing, every stage of your program supported end-to-end under one partner.
Image

Built Around Your Program

Proven, standardized workflows with the flexibility to adapt or develop new approaches when your program demands it. Every manufacturing strategy is aligned tothe specific scientific, regulatory, and commercial requirements of your therapy.

Drug Substance Manufacturing Track Record

0+ years
of cGMP manufacturing experience
0
Critical Observations
Image
Image
3
BLA Submissions
0+
products manufactured
Specialist inspecting a stainless steel solution preparation tank for large-scale biologics and small molecule manufacturing.

Ready to Scale Your Drug Substance Program?

Let’s talk about your biologics development and manufacturing needs.